Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China · Delayed Price · Currency is CNY 11.98
+0.15 (1.27%)
Feb 3, 2026, 3:04 PM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.29B CNY in the quarter ending September 30, 2025, with 5.01% growth. This brings the company's revenue in the last twelve months to 5.22B, up 4.57% year-over-year. In the year 2024, Yifan Pharmaceutical had annual revenue of 5.16B with 26.84% growth.
Revenue (ttm)
5.22B
Revenue Growth
+4.57%
P/S Ratio
2.38
Revenue / Employee
1.27M
Employees
4,098
Market Cap
12.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.16B | 1.09B | 26.84% |
| Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
| Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
| Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
| Dec 31, 2020 | 5.40B | 213.54M | 4.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Zhejiang Jolly Pharmaceutical Co.,LTD | 2.81B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Zhejiang Wolwo Bio-Pharmaceutical | 1.05B |
| Shanghai InnoStar Bio-tech | 829.92M |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |